Nicotine pouches: marketed as “clean” but linked to youth use, dual use, and dependency. Pharmacists can help by offering evidence-based cessation guidance.
Read More: hubs.li/Q04xRvXb0 #pharmacy #publichealth
Discover how James Barnes, CPhT, is redefining pharmacy technician impact through patient connection and national recognition.
Insightful read for pharmacy leaders: hubs.li/Q04xRv1T0 #PharmacyLeadership #PatientCare
New study finds age and physical comorbidities, not psychiatric diagnoses, drive polypharmacy in psychiatric inpatients, highlighting the need for routine deprescribing reviews.
Read More: hubs.li/Q04xRsQR0
How can digital pharmacy drive trust? TelyRx CEO Vanessa Slowey shares how clinical oversight and FDA standards are essential for safe, transparent care.
Read More: hubs.li/Q04xRrYP0 #Pharmacy #DigitalHealth
New data show adults with serious mental illness are prescribed GLP-1s at similar or higher rates than others. Pharmacists play a key role in equitable access and safety.
Read More: hubs.li/Q04xRmbH0 #Pharmacy #MentalHealth
How will ACIP policy changes affect vaccine access and pharmacist reimbursement? Explore key impacts on coverage and the VFC program in our latest Worth a Shot episode.
Read More: hubs.ly/Q04xRlNs0 #VaccineEquity #ManagedCare
FDA approves finerenone for CKD in type 1 diabetes, the first advance in 30+ years. Clinical pharmacists: review potassium and CYP3A4 interactions.
Read More: hubs.li/Q04xRl920
Discover how pharmacists can help close HPV prevention gaps and drive vaccine completion.
Get insights from Madeline Sutton on Scripted for Her: hubs.li/Q04xRj0b0 #HPV #Pharmacy #WomensHealth
Childhood pneumonia hospitalizations fell 51% after routine PCV13, but disparities remain for at-risk, Black, and lower-income children. Pharmacists can help boost screening and vaccine completion.
Read More: hubs.li/Q04xKRVV0
Here's why you should attend the Fall 2026 Total Pharmacy Solutions Summit, from Dorrit Trate, MHA, MBA, Nancy Lyons, BSPharm, MBA, CDCES, and keynote speaker E.J. Stoepfel, RPh, MBA-HCA. Register: hubs.li/Q04x9VsG0
With over 40% of primary care physicians expected to reach retirement age within the next 8 years, utilizing pharmacists to their full scope of practice is becoming an urgent necessity for health care access.
Listen to the full episode here: hubs.li/Q04xKN-z0
Student pharmacists are transforming community health as new research shows SDOH training and student-led initiatives build clinical confidence and advance health equity.
Discover their impact: hubs.li/Q04xKLZR0
Stay ahead of respiratory vaccine updates: Kelly Goode, PharmD, shares the latest on flu, COVID-19, and RSV guidance, plus billing tips and coadministration strategies for pharmacists.
Read More: hubs.li/Q04xKKMt0 #pharmacy #vaccines #publichealth
Discover how pharmacy leaders use timing and operational cycles to drive success. Explore the "Law of Rhythm" and "Law of Gestation" in this month's episode of Dispensing Leadership.
Read More: hubs.li/Q04xDNWj0 #PharmacyLeadership #Healthcare
New research links 1+ year of HRT to a 10% lower risk of dementia and 16% lower risk of Alzheimer’s. Pharmacists play a key role in early intervention and patient counseling.
Learn More: hubs.li/Q04xDN0_0
AI and automation are redefining pharmacy care. TelyRx CEO Vanessa Slowey shares how predictive analytics and automated workflows help pharmacists deliver proactive, patient-focused care.
Read More: hubs.li/Q04xDMpm0
FDA approves leniolisib (Joenja) for children 4 to 11 with APDS, the first targeted therapy for this age group. New tablet strengths offer earlier intervention for improved outcomes.
Read More: hubs.li/Q04xDLFD0
When GLP-1 monotherapy is not enough in T2D, new guidelines urge clinical pharmacists to personalize treatment intensification and address access barriers.
Explore the recommendations: hubs.li/Q04xx4Mg0
Key risk factors for long COVID after hospitalization, such as female sex, severe illness, ICU stay, incomplete vaccination, and hypertension, highlight urgent needs for pharmacist-led follow-up.
Read More: hubs.li/Q04xw-l00
New data show Omnipod 5 users with type 1 diabetes kept a 17.9% boost in time in range and 1.14% HbA1c drop over 12 months, underscoring the pharmacist’s role in device adoption.
Read More: hubs.li/Q04xwZJn0



